跳至主要内容
临床试验/KCT0002038
KCT0002038招募中未知

Response-based treatment of high-risk neuroblastoma

Samsung Medical Center0 个研究点目标入组 54 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
招募中
入组人数
54

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
o Limit 至 o Limit(—)
性别
All

入选标准

  • 1. Patients with newly diagnosed high risk neuroblastoma
  • 2. Patients with measurable or evaluable disease
  • 3. Patients with informed consent

排除标准

  • 1. Patients with progressive disease or relapse
  • 2. Patients who underwent high dose chemotherapy before
  • 3. Patients with organ dysfunction as follows (creatinine elevation > 3 x upper limit of normal, Total bilirubin > 3 x upper limit of normal, aspartate transaminase/alanine transaminase > 5 x upper limit of normal), ejection fraction <40%)
  • 4. Pregnant or nursing women

研究者

相似试验